MC3T3-E1 cells proliferation

MC3T3-E1 cells proliferation refers to the biological process of cell division and population expansion in the MC3T3-E1 murine osteoblast precursor cell line. Originally derived from newborn mouse calvaria, this cell line is a cornerstone of bone biology research due to its ability to differentiate into mature osteoblasts and form a mineralized extracellular matrix (Kodama et al., 1981, PMID: 7050201). Proliferation of these cells is a critical early stage in the osteogenic lineage, preceding the expression of maturation markers like alkaline phosphatase and osteocalcin (Czekanska et al., 2012, PMID: 22810213). While it is a vital parameter for assessing the anabolic potential of drugs, it is a complex cellular phenotype rather than a single molecular target such as a receptor or enzyme. Therapeutic agents like Bone Morphogenetic Protein 2 (BMP-2) or parathyroid hormone analogs influence this process by binding to specific cell-surface receptors and activating downstream signaling cascades (Wang et al., 1990, PMID: 2162444). Consequently, monitoring MC3T3-E1 proliferation serves as a functional assay for evaluating bone-forming activity in the context of treating diseases like osteoporosis or accelerating fracture healing.

Other names

MC3T3-E1 cell growthOsteoblast proliferation (MC3T3-E1)Murine osteoblast precursor proliferation

Not applicable; this is a cellular process. Drugs modulate this process by targeting specific receptors (e.g., BMPR, PTHR1) or signaling pathways (e.g., Wnt/β-catenin, MAPK) to influence the rate of cell division.